Your browser doesn't support javascript.
loading
Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105.
Hershman, Dawn L; Unger, Joseph M; Hillyer, Grace Clarke; Moseley, Anna; Arnold, Kathryn B; Dakhil, Shaker R; Esparaz, Benjamin T; Kuan, Ming C; Graham, Mark L; Lackowski, Douglas M; Edenfield, William J; Dayao, Zoneddy R; Henry, N Lynn; Gralow, Julie R; Ramsey, Scott D; Neugut, Alfred I.
Afiliación
  • Hershman DL; Columbia University Medical Center, New York, NY.
  • Unger JM; SWOG Statistics and Data Management Center, Seattle, WA.
  • Hillyer GC; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Moseley A; Columbia University Medical Center, New York, NY.
  • Arnold KB; SWOG Statistics and Data Management Center, Seattle, WA.
  • Dakhil SR; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Esparaz BT; SWOG Statistics and Data Management Center, Seattle, WA.
  • Kuan MC; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Graham ML; Wichita NCORP/Cancer Center of Kansas - Wichita, Wichita, KS.
  • Lackowski DM; Heartland NCORP/Cancer Care Specialist of Central Illinois, Decatur, IL.
  • Edenfield WJ; Kaiser Permanente NCORP/Kaiser Permanente NCAL, San Leandro, CA.
  • Dayao ZR; Southeast COR NCORP/Waverly Hematology/Oncology, Cary, NC.
  • Henry NL; Northwest NCORP/Central Interstate Medical Office Department Hematology/Oncology, Portland, OR.
  • Gralow JR; NCORP of the Carolinas (Greenville Health System), Greenville, SC.
  • Ramsey SD; New Mexico Minority Underserved NCORP/University of New Mexico Cancer Center, Albuquerque, NM.
  • Neugut AI; University of Michigan, Ann Arbor, MI.
J Clin Oncol ; 38(19): 2122-2129, 2020 07 01.
Article en En | MEDLINE | ID: mdl-32369401
PURPOSE: Nonadherence to aromatase inhibitors (AIs) for breast cancer is common and increases the risk of recurrence. Text messaging increases adherence to medications for chronic conditions. METHODS: We conducted a randomized clinical trial of text messaging (TM) versus no text messaging (No-TM) at 40 sites in the United States. Eligible patients were postmenopausal women with early-stage breast cancer taking an AI for > 30 days with a planned duration of ≥ 36 months. Test messages were sent twice a week over 36 months. Content themes focused on overcoming barriers to medication adherence and included cues to action, statements related to medication efficacy, and reinforcements of the recommendation to take AIs. Both groups were assessed every 3 months. The primary outcome was time to adherence failure (AF), where AF was defined as urine AI metabolite assay results satisfying one of the following: < 10 ng/mL, undetectable, or no submitted specimen. A stratified log-rank test was conducted. Multiple sensitivity analyses were performed. RESULTS: In total, 724 patients were registered between May 2012 and September 2013, among whom,702 patients (348 in the text-messaging arm and 354 in the no-text-messaging arm) were eligible at baseline. Observed adherence at 36 months was 55.5% for TM and 55.4% for No-TM. The primary analysis showed no difference in time to AF by arm (3-year AF: 81.9% TM v 85.6% No-TM; HR, 0.89 [95% CI, 0.76 to 1.05]; P = .18). Multiple time to AF sensitivity analyses showed similar nonsignificant results. Three-year self-reported time to AF (10.4% v 10.3%; HR, 1.16 [95% CI, 0.69 to 1.98]; P = .57) and site-reported time to AF (21.9% v 18.9%; HR, 1.31 [95% CI, 0.86 to 2.01]; P = .21) also did not differ by arm. CONCLUSION: To our knowledge, this was the first large, long-term, randomized trial of an intervention directed at improving AI adherence. We found high rates of AI AF. Twice-weekly text reminders did not improve adherence to AIs. Improving long-term adherence will likely require personalized and sustained behavioral interventions.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inhibidores de la Aromatasa / Envío de Mensajes de Texto Tipo de estudio: Clinical_trials / Guideline Límite: Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inhibidores de la Aromatasa / Envío de Mensajes de Texto Tipo de estudio: Clinical_trials / Guideline Límite: Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos